Profound Medical Corp. announced that its management will present a business update at the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 22, 2026.
Key takeaways
Management will present a business update at the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 22, 2026.
The presentation will be broadcast live and archived on the company's website.
The company is a commercial-stage medical device company developing AI-powered, MRI-guided, incision-free therapies.
The company's flagship platform, TULSA-PRO, is designed for MRI-guided, incision-free prostate therapy.
The company also commercializes Sonalleve, an MRI-guided therapy for pain palliation and gynecologic conditions.